fbpx
  • Home
  • Study Details
By physician referral or invitation only

Biomarker for cervical cancer screening study

To determine if plasma circulating HPV DNA (cHPVDNA) has potential as a non-invasive biomarker for identification and treatment monitoring of cervical intraepithelial neoplasia grades 2-3 by characterizing correlation between plasma cHPVDNA levels and cervical intraepithelial neoplasia grade prior to intervention and after excision.

Age & Gender

  • 18 years ~ 99 years
  • Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Ashley Weiner
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical

Study Topics

Cancer (Cervical)
Immune System/Infections
Sexual and/or Reproductive Health
Women's Health

IRB Number

19-2196

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research